Marcel A Behr Selected Research

1-tuberculosinyladenosine

10/2020	Heterologous Production of 1-Tuberculosinyladenosine in Mycobacterium kansasii Models Pathoevolution towards the Transcellular Lifestyle of Mycobacterium tuberculosis.
1/2019	Mycobacterium tuberculosis releases an antacid that remodels phagosomes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marcel A Behr Research Topics

Disease

31	Tuberculosis (Tuberculoses) 01/2022 - 01/2002
26	Infections 06/2022 - 02/2003
5	Crohn Disease (Crohn's Disease) 01/2013 - 01/2008
3	COVID-19 01/2022 - 01/2021
3	Paratuberculosis (Johne's Disease) 12/2015 - 01/2008
2	Cerebral Malaria 01/2020 - 01/2012
2	Pulmonary Tuberculosis 04/2019 - 01/2018
2	autosomal recessive Candidiasis familial chronic mucocutaneous 04/2016 - 07/2014
2	Candidiasis (Moniliasis) 04/2016 - 07/2014
1	Vaccine-Preventable Diseases 01/2022
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2022
1	Common Cold 01/2022
1	Bovine Tuberculosis 01/2022
1	Porcine Reproductive and Respiratory Syndrome (PRRS) 01/2021
1	Persistent Infection 10/2020
1	Cough 01/2020
1	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 01/2020
1	Neuroinflammatory Diseases 01/2020
1	Latent Tuberculosis 01/2020
1	Lymphoma (Lymphomas) 04/2016
1	Mycoses (Diseases, Fungus) 04/2016
1	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 04/2016
1	Lymphatic Diseases 03/2014
1	Clostridium Infections 06/2013
1	Vitamin D Deficiency 01/2013
1	Hypoxia (Hypoxemia) 12/2010
1	Gastroenteritis 05/2010
1	Confusion (Bewilderment) 02/2002

Drug/Important Bio-Agent (IBA)

15	VaccinesIBA 06/2022 - 01/2002
7	Proteins (Proteins, Gene)FDA Link 01/2020 - 02/2005
6	DNA (Deoxyribonucleic Acid)IBA 11/2015 - 01/2004
5	CytokinesIBA 01/2022 - 11/2008
4	AntigensIBA 02/2021 - 09/2006
3	Tuberculin (PPD)IBA 01/2022 - 09/2006
3	Attenuated VaccinesIBA 01/2022 - 09/2007
3	AerosolsIBA 02/2021 - 11/2008
3	IronIBA 10/2020 - 11/2013
3	Indicators and Reagents (Reagents)IBA 01/2020 - 09/2006
3	Biological ProductsIBA 06/2011 - 09/2005
2	LipidsIBA 10/2020 - 01/2020
2	1-tuberculosinyladenosineIBA 10/2020 - 01/2019
2	Ethylnitrosourea (N-Ethyl-N-nitrosourea)IBA 01/2020 - 01/2012
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 04/2016 - 07/2014
2	Peptidoglycan (Murein)IBA 02/2015 - 07/2009
2	Vitamin D FDA LinkGeneric 01/2013 - 07/2010
1	Anti-Bacterial Agents (Antibiotics)IBA 10/2021
1	Clarithromycin (Biaxin)FDA LinkGeneric 10/2021
1	RNA (Ribonucleic Acid)IBA 10/2021
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2021
1	Interleukin-12 (IL 12)IBA 01/2021
1	Pattern Recognition ReceptorsIBA 01/2021
1	Virulence Factors (Pathogenicity Factors)IBA 10/2020
1	Levofloxacin (Levaquin)FDA Link 01/2020
1	1,2-dihydroxy-4-(nitroethenyl)benzene (SL-1)IBA 01/2020
1	Pharmaceutical PreparationsIBA 01/2020
1	AntibodiesIBA 04/2019
1	Tuberculosis VaccinesIBA 01/2018
1	BCG Vaccine FDA Link 01/2018
1	Transcription Factors (Transcription Factor)IBA 12/2016
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 12/2016
1	ras-GRF1 (ras GRF1)IBA 04/2016
1	SiderophoresIBA 12/2015
1	mycobactinsIBA 12/2015
1	Aryl Hydrocarbon Receptor Nuclear TranslocatorIBA 11/2015
1	Tryptophan (L-Tryptophan)FDA Link 11/2015
1	EnzymesIBA 11/2015
1	VitaminsIBA 08/2015
1	CarbohydratesIBA 08/2015
1	Heparin (Liquaemin)FDA LinkGeneric 11/2013
1	heparin-sepharoseIBA 11/2013
1	heparin-binding hemagglutininIBA 11/2013
1	Proton Pump InhibitorsIBA 06/2013
1	InterleukinsIBA 01/2013
1	ChemokinesIBA 01/2013
1	1,25-dihydroxyvitamin DIBA 01/2013
1	Phosphotransferases (Kinase)IBA 01/2012
1	Interferon-gamma (Interferon, gamma)IBA 01/2012
1	EpitopesIBA 12/2010
1	Phenobarbital (Luminal)FDA Link 05/2010
1	Calcitriol (Calcijex)FDA LinkGeneric 01/2010
1	DefensinsIBA 01/2010
1	Genetic Markers (Genetic Marker)IBA 10/2009
1	Toll-Like Receptors (Toll-Like Receptor)IBA 07/2009
1	Interferon Type IIBA 07/2009

Therapy/Procedure

5	Therapeutics 07/2014 - 01/2008
1	N95 Respirators 01/2022
1	Mechanical Ventilators (Ventilator) 01/2022
1	Duration of Therapy 11/2021
1	Breast Implants (Breast Implant) 11/2018
1	Prostheses and Implants (Prosthesis) 11/2018